T cell receptor at the major histocompatibility complex class II–peptide interface (TCR–MHC class II–peptide interface)

The T cell receptor at the MHC class II–peptide–TCR interface refers to the highly specific molecular interaction between the T cell receptor on CD4+ (helper) T cells and antigenic peptides presented by major histocompatibility complex (MHC) class II molecules on antigen-presenting cells. This interface is crucial for the activation and specificity of adaptive immune responses. The TCR recognizes a composite surface formed by the peptide and the MHC class II molecule, with the TCR docking diagonally across the peptide-binding groove of MHC II. The interface accommodates significant diversity due to MHC polymorphism and TCR variability, enabling recognition of diverse pathogens but also contributing to autoimmunity and transplant rejection when self or alloantigens are recognized. This interaction is a pivotal checkpoint in immune regulation, and its dysregulation underlies various disease processes, making its components important therapeutic targets in immunology.

Other names

TCR–MHC II interfaceTCR–peptide–MHC class II complexT cell receptor–peptide–MHC complexTCR–pMHC II interface

Blockade of TCR signaling: Antibodies targeting CD3, CD4, or the TCR complex; MHC class II blockade: Antibodies that prevent peptide presentation; Peptide competition/alters: Competing or modified peptides that prevent recognition by pathogenic TCRs; Immunomodulation: Agents suppress or modulate T cell receptor–MHC class II engagement or downstream signaling